Delivery Order SPE2DB20D3103-SPE2DB23FN9D6
Award Date 7/6/23
Potential Completion Date 7/7/23
Potential Value $6.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of 4,564,741,740 units of the pharmaceutical product Droxidopa 100 mg capsules to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for a ceiling value of $7,021.56. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,143,796 units of Droxidopa 300 mg capsules, a medication used to treat neurological conditions. The contract has a firm fixed price and a ceiling value of $30,036.24, with a performance period extending until May 6, 2025. The contract is not set aside for any specific...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $85,586.62 firm fixed-price contract is for the delivery of 4,564,640,389 units of the drug Droxidopa 100 mg capsules. The contract has a completion date of May 20, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4,565,162,122 units of the pharmaceutical product droxidopa 300 mg capsule. The $5,079.41 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor. The contract has an ultimate completion date of July 1, 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery...
- This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of medical products to the U.S. federal government. The $30,495.60 firm-fixed price contract is for the delivery of 90-count bottles of 200 mg Droxidopa capsules. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
- This is a Delivery Order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $30,495.60 firm fixed price contract is for the supply of 90-count capsules of the drug droxidopa 200 mg. The award does not have a set-aside designation. This Delivery Order is placed against a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,555.09, is for the delivery of 4567678075 ! DROXIDOPA 100 MG CAPSULE 90S. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- The U.S. Defense Logistics Agency (DLA) awarded a $13,920.91 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 90-count packages of the drug DROXIDOPA 100 MG CAPSULE. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order for the supply of 4,563,636,772 DROXIDOPA 100 MG CAPSULE 90S with a potential value of $6,594.58 and a completion date of February 13, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,239.99 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, to provide 4566054689 DROXIDOPA 200 MG CAPSULE 90S. This contract has an ultimate completion date of October 9, 2024 and is not set aside for a specific socioeconomic program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...